Non-Invasive Genomic Diagnostics & Monitoring to Improve Outcomes

Laboratory Tests for Organ Transplants

Rejection Biomarkers • Infectious Disease Management • Drug Monitoring

What would it mean for transplant patient care if you could streamline your most critical diagnostics with one lab?

Seventy-five percent of transplant centers across the U.S. trust Eurofins Viracor for their immunocompromised patient testing. We are a lab specifically dedicated to this special population, delivering the most comprehensive, accurate results with the fastest turnaround times. You can be sure your most time-sensitive diagnostics are in good hands.

Assess pre-transplant donor eligibility screening, HLA & immunogenetics testing
Identify post transplant Subclinical Acute or Acute rejection
Rule out infection, manage immunosuppression levels and toxicity
Test for COVID-19 SARS-CoV-2 (Viral Load, Antibody, Immunity)

Pre-Transplant Testing

Utilizing FDA-approved screening kits for required and rapid testing of donor specimens — human cells, tissues and cellular- and tissue-based products (HCT/Ps) — healthcare providers can trust Eurofins Viracor to deliver the data needed to aid in the critical determination of ongoing or previous infections.

Our timely and actionable reporting delivers results when it matters most — bridging the gap from donation to release to transplant.

Solid Organ Transplant Testing

When your SOT patients face complications, you need accurate and rapid results to minimize infection and graft failure.

Monitoring rejection, infection, immune system function, and triazole antifungal drug levels in advance of clinical symptoms provides the optimal opportunity for successful intervention, which will prevent transplant rejection and treatment

Blood and Marrow Transplant Testing

Every BMT/HSCT procedure comes with complications that can very quickly cascade into a life-threatening situation. Symptoms often mimic each other, making diagnosis and management complex.

Diagnose and differentiate BMT complications like infections, GvHD, graft failure and immune reconstitution
Monitor antifungal drug levels to keep patients in the therapeutic range

Managing Infectious Disease in Transplant Patients

Speed. Quality. Service.

Whether you are trying to rule out or manage an infection like SARS-CoV-2, CMV or BKV, Eurofins Viracor offers a comprehensive test portfolio to help you make better treatment decisions.

Learn More About Managing ID

Molecular Assays Designed to Help Reduce False Negatives and Under-quantification

Eurofins Viracor’s qPCR assays often target two regions within the pathogen genome, utilizing unique primer and probe sets for each target site. The driving principle behind our multiple-target assay design is that when a polymorphism occurs in one assay target, the additional sets of primers and probes for the alternate target region will still detect and accurately quantify the pathogen, and thus reduces the likelihood of under-quantification or a false negative result.

Learn More

Assay Refinement Helps Account for New Strains or Mutations that Might Otherwise be Missed

By utilizing nucleic acid sequence databases, each qPCR assay is regularly assessed to verify that new pathogen strains or genetic polymorphisms that arise will not lead to a false negative result. If a new pathogen strain or genetic polymorphism is identified, our current assay is refined and revalidated to ensure that accurate test results are always reported.

Eurofins Viracor designs each of our assays to account for all strains, serotypes, and clinical isolates - not just the most common ones. This is especially beneficial for immunocompromised patients who may be more likely to be infected with multiple or unusual strains.

Learn More

Variety of Accepted and Validated Specimen Types Give You More Options

Not only are Eurofins Viracor’s assays extremely sensitive with rapid turnaround time, but they can identify pathogens using many different types of clinical specimens, such as plasma, urine, cerebrospinal fluid, lung tissue, bone marrow aspirate, throat specimens and fecal specimens, among other fluids and tissues. By providing you more options you can determine what is best for your patient and capture localized viral presentations.

Learn More

Spotlight on COVID-19 Diagnostics

Eurofins Viracor has been at the forefront of fighting COVID-19

In partnership with the National Kidney Registry, Eurofins Viracor offers COVID-19 testing to help support the continuation of paired exchanges and transplant surgeries during the pandemic. In addition, we introduced Labs@HOME, a mobile phlebotomy service for high risk patients that need to avoid a hospital visit. No other lab can deliver the full spectrum of necessary testing and services this patient population requires, and that's why hundreds of hospitals and transplant centers trust Viracor for their clinical diagnostic needs.

Let us help you streamline transplant testing for your most critical patients.

COVID-19

Experience and Service You Can Trust

Eurofins Viracor was one of the first laboratories in the U.S. dedicated to serving the distinctive needs of transplant patients. We know transplant diagnostics.

As a specialty lab partnering with hundreds of academic hospitals & transplant centers, Viracor understands the complex diagnostic challenges that can occur, and your related testing needs for pre and post transplantation.

35 years of experience in clinical diagnostic testing
Partner with 75% of U.S. transplant programs nationwide
CAP & CLIA accredited laboratory

Results In Time To Make A Difference

We know that accelerated, clinically meaningful results are critical to transplant patient outcomes. This is why we’re committed to bringing you fast, accurate results that can help you counter infections and minimize graft failure.

Same day results (within 24 hours or sooner from specimen receipt) for:

Viral, fungal, and bacterial quantitative PCR tests including critical pathogens such as CMV, BKV, HHV-6, among others
Therapeutic anti-fungal and immunosuppressive drug monitoring assays
COVID-19 SARS-CoV-2 Diagnostics

New to Eurofins Viracor?

Get Results Faster, When It Matters Most.

With over 35 years of specialized expertise in infectious disease, immunology and allergy testing for immunocompromised and critical patients, Eurofins Viracor is committed to helping medical professionals, transplant teams and reference labs get results faster, when it matters most.